By expenditures
| Name | Title | Type |
|---|---|---|
| Elizabeth Wilson | Chief Financial Officer & Treasurer | Auditee |
| Chelsea Hill | CONTROLLER | Auditee |
| Susan Maloney | Managing Director | Auditee |
| Andrea Caladie | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351286 | 2024 | 2025-03-31 | Baker Tilly US LLP | $17.61M |
| 299036 | 2023 | 2024-03-28 | Baker Tilly US LLP | $17.97M |
| 21091 | 2022 | 2023-01-19 | Baker Tilly US LLP | $20.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 21091 | 2022 | 2023-01-19 | 598599 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 598598 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 598597 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 598596 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 598595 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 22157 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 22156 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 22155 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 22154 | 2022-001 | Significant Deficiency | - | N |
| 21091 | 2022 | 2023-01-19 | 22153 | 2022-001 | Significant Deficiency | - | N |